Finance

Beta
Lists
SBS:FRA
Stratec SE
€17.16
+3.00%
(+0.50) 1D
May 29, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SBS...
Open
€17.16
High
€17.16
Low
€17.16
Mkt. cap
217.14M
Avg. vol.
66.00
Volume
0.00
Dividend
3.50%
Quarterly dividend
€0.15
Ex-dividend date
Jun 24, 2026
52-wk high
€32.20
52-wk low
€16.60
Shares outstanding
11.96M
No. of employees
1K
Open
€17.16
High
€17.16
Low
€17.16
Mkt. cap
217.14M
Avg. vol.
66.00
Volume
0.00
Dividend
3.50%
Quarterly dividend
€0.15
Ex-dividend date
Jun 24, 2026
52-wk high
€32.20
52-wk low
€16.60
Shares outstanding
11.96M
No. of employees
1K
News stories
From sources across the web
Profile
STRATEC SE is a company with worldwide operations that designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and biotechnology - particularly in the field of in-vitro-diagnostics. As a classic original equipment manufacturer supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also provides sample preparation solutions, system software and integrated laboratory software. STRATEC is also responsible for development documentation, testing, delivery of systems, and the supply of spare parts and complex consumables for diagnostic and medical applications. STRATEC's customers are well known diagnostic companies like DiaSorin, Abbott, SIEMENS, Bio-Rad or Hologic. Wikipedia
About Stratec SE
CEO-
Employees1.4K
Founded1979
Headquarters-
SectorMedical device
Websitestratec.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
59.30M
59.30M
57.00M
75.28M
Cost of goods sold
43.32M
43.32M
43.70M
56.31M
Cost of revenue
43.32M
43.32M
43.70M
56.31M
Research and development expenses
2.71M
2.71M
1.59M
2.78M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.75M
9.75M
8.47M
10.82M
Operating expense
13.11M
13.11M
9.78M
11.19M
Total operating expenses
56.43M
56.43M
53.48M
67.50M
Operating income
2.87M
2.87M
3.52M
7.78M
Other non operating income
-31.00K
-31.00K
-117.00K
219.00K
EBT including unusual items
1.65M
1.65M
2.38M
-826.00K
EBT excluding unusual items
1.86M
1.86M
2.38M
5.55M
Income tax expense
346.00K
346.00K
878.00K
3.52M
Effective tax rate
21.01%
21.01%
36.91%
-426.03%
Other operating expenses
649.00K
649.00K
-274.00K
-2.41M
Net income
1.30M
1.30M
1.50M
-4.34M
Net profit margin
2.19%
2.19%
2.63%
-5.77%
Earnings per share
-
-
-
-
Interest and investment income
60.50K
60.50K
33.00K
8.00K
Interest expense
-1.04M
-1.04M
-1.06M
-955.00K
Net interest expenses
-981.50K
-981.50K
-1.02M
-947.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
7.47M
7.47M
8.04M
10.71M
Gain or loss from assets sale
-
-
13.00K
3.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer